Minghui Pharmaceutical (Hangzhou) Ltd
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Minghui Pharmaceutical (Hangzhou) Ltd
RECRUITINGPhase 3NCT07262476
Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease
This is a multicenter, open-label extension (OLE) study of MHB018A in subjects with moderate-to-severe TED.
Sponsor: Minghui Pharmaceutical (Hangzhou) LtdEnrolling: 2581 location
Thyroid Eye Disease (TED)
RECRUITINGPhase 3NCT07257185
MHB018A Treatment in Patients With Chronic Thyroid Eye Disease
The primary objective of this study is to investigate the efficacy, safety, and tolerability of MHB018A, a humanized anti-IGF1R antibody, administered Q4W for 6 months, in...
Sponsor: Minghui Pharmaceutical (Hangzhou) LtdEnrolling: 1501 location
Thyroid Eye Disease (TED)